
Tips for getting through treatment with a radiation therapy mask
Stereotactic radiation therapy is a cutting-edge technique used to treat small, well defined tumours, including advanced prostate cancer where the disease has started to spread to other parts of the body.
In the past, men with prostate cancer would be treated with hormone therapy and chemotherapy, which are often associated with negative side effects. Icon Group’s recent TRANSFORM study, published in the International Journal of Cancer, found that stereotactic radiation therapy can delay progression to these more toxic treatments for more than two years.
In the video below, Icon Radiation Oncologist and TRANSFORM Principal Investigator Dr Patrick Bowden discusses the TRANSFORM study and what this means for men with advanced prostate cancer.
The content on the Icon Cancer Centre website is for informational purposes only and should not be considered medical advice. It is not a substitute for consultation with a qualified medical practitioner. For personalised medical guidance, please consult with your GP or another qualified healthcare provider.
Discover our comprehensive collection of content designed to inform, support, and guide you through every aspect of cancer care. From the latest news and updates to personal patient experiences and educational resources, these materials provide valuable insights to help you better understand cancer, treatment options, and the journey ahead.